Myriad Genetics, Pharma Mar Explore PGx Strategy for DNA-Damaging Synthetic Alkaloid PM1183

Posted: July 31, 2012 at 10:11 am

Michael Rhodes has left his position at Life Technologies to join NanoString Technologies as director of collaboration and applications development, where he will focus on digital gene expression.

Rhodes held various positions at Life Tech, including most recently senior manager sequencing portfolio. He joined Applied Biosystems in 1999 in the genetic analysis division before the company merged with Invitrogen and became Life Tech.

In his new position, he will report to Joe Beechem, who also recently joined NanoString from Life Tech, where he was most recently vice president, head of advanced sequencing and head of global sequencing chemistry, biochemistry, and biophysics.

Quanterix has tapped Paul Chapman to be company president and CEO. Chapman recently was VP of EMD Millipore's BioPharm Process Solutions business, where he was responsible for marketing and R&D teams, and was previously VP of hospital solutions for Roche Near Patient Testing in Austria. Chapman also formerly was international business development manager at Roche Molecular Diagnostics, and he held a range of positions at Roche Diagnostics Canada.

Edison Liu has been elected to the Foundation for the National Institutes of Health's board of directors. His term began on June 19.

Liu is the president and CEO of the Jackson Laboratory and president of the Human Genome Organization. He joined the Jackson Laboratory from the Genome Institute of Singapore, where he was the founding executive director. Prior to that, he was the scientific director of the National Cancer Institute's division of clinical sciences.

See the rest here:
Myriad Genetics, Pharma Mar Explore PGx Strategy for DNA-Damaging Synthetic Alkaloid PM1183

Related Post

Comments are closed.

Archives